A Fourth Vaccine on the Horizon?

In a new analysis of its phase three trial in the United States, AstaZeneca has determined their COVID-19 vaccine to be 76% effective. This new data shows a three percent change from their initial report earlier this week stating their efficacy rate to be 79% effective against the coronavirus disease. AstraZeneca’s original filing came under […]

Read More

March Madness 2021 Boom or Bust for Crude

Crude has been the underdog since Covid-19 broke onto the scene in early March of 2020. We have seen historic contango, negative trading, inventories at the verge of 100% capacity. However, we have also seen refineries curtailing production and shutting down, crude breaking technical level after level, OPEC + committing to decreased outputs, a Texas […]

Read More

Life After Covid – A Return to a Sense of Normalcy

After a year of uncertainty and instability in the market created by COVID-19 and a global shutdown, we are starting to see signs of a return to normalcy. Over the past 8 weeks there has been a gradual decline in COVID-19 cases nationally. According to Bloomberg business, “retail gasoline sales rose last week to just […]

Read More

Green Means Go – Johnson & Johnson Vaccine Authorized

As new variants of COVID-19 emerge, the Johnson & Johnson vaccine has been given the green light by the U.S. FDA for emergency use. This will be the first single shot vaccine released to fight COVID-19. As early as Tuesday morning, 3.9 million doses of the Johnson & Johnson vaccine will be distributed to states, […]

Read More

Johnson & Johnson Single Shot Vaccine Deemed Safe by FDA

This week the United States passed 500,000 Covid-19 related deaths, a devastating milestone. While we continue our fight against this global pandemic, there are signs that things will get better sooner rather than later. Today the FDA endorsed Johnson & Johnson’s Covid-19 vaccine for emergency use. This is welcomed news for the fight against Covid-19 and critical step […]

Read More

200 Million More on The Way

President Biden announced Tuesday evening that the United States is aiming to purchase an additional 200 million does of COVID-19 vaccines. Securing these supplemental doses would be enough to inoculate most Americans by the end of the summer. The Biden Administration will purchase 100 million doses of each of the two current vaccines on the […]

Read More